Back to Trades
Sethuraman Natarajan
President, Research & Develop.CIK: 0001873394
Sethuraman Natarajan, President, Research & Develop., has filed 3 insider trading reports covering 1 company. Total disclosed trading volume is $1.5M. Sales ($398.8K) outpace purchases ($0) over this period. Insider sales are common for diversification and personal financial planning and should be evaluated with full context. The largest single filing involves Entrada Therapeutics, Inc. (TRDA). All transactions sourced from SEC Form 4 filings.
Total Volume
$1.5M
Purchases
$0
Sales
$398.8K
Companies
1
Trading History (3 filings)
Sethuraman NatarajanPresident, Research & Develop.
Filed May 4, 2026
Sell
$398.8K
1 sale
Sethuraman NatarajanPresident, Research & Develop.
Filed Mar 3, 2026
Grant
$0
1 grant
Sethuraman NatarajanPresident, Research & Develop.
Filed Sep 4, 2025
Other
$0